中文

Reagent

EasyNAT Malaria Assay

Ongoing Challanges

  • Climate change expands malaria zones; conflict disrupts elimination efforts. Mosquito resistance to insecticides and parasite resistance to artemisinin-based therapies are increasing.

  • Rapid Diagnostic Tests (RDTs) can miss low-parasitemia infections and specific strains. Microscopy is labor-intensive.

  • POC molecular diagnostics are crucial for bridging the gap between central labs and field needs for malaria elimination.[1]

Reference
[1] WHO Malaria Report, 2023

Product Overview

The EasyNAT® Malaria Assay is a POCT DNA test intended for the rapid qualitative detection of *Plasmodium* species (malaria parasite) in oropharyngeal swab and skin lesion exudate swab samples.

  • Results available within 49 minutes

  • Designed to provide an accurate LOD: 6 copies/mL

Clinical Value

  • Portable, low-cost POC PCR systems could revolutionize malaria surveillance in endemic regions.

  • Accurately identifies *P. falciparum*, *P. vivax*, and mixed infections.

  • Higher sensitivity for detecting low-parasitemia and asymptomatic infections, which is critical for elimination efforts.

Product Resources

EasyNAT® Malaria Assay
Brochure
EasyNAT® Malaria Assay
Instructions for Use
EasyNAT® Malaria Assay
SOP
Reagent
System

MultNAT

PortNAT

EasyNAT

Solution
Primary
Healthcare
Sexually Trasmitted Infections
Public Health
Tuberculosis
Respiratory
Infections
Livestock
About us

Company Profile

R&D Strength

Social Responsibility